Technologies for Vaccines for COVID-19

with
Steve Chamow
Dr. Steve Chamow is back by popular demand for an extended conversation on COVID-19 drug discovery. Join us to learn more about the availability of technologies for therapeutics and vaccines and opportunities to shorten the timeline of clinical drug development.
This is a single-session event.
This event has
one
sessions.
Steve Chamow

Upcoming dates

No events currently scheduled
Our events are recorded. Non-downloadable, password-protected recordings are shared only with ticket holders.
Let us know
when you’d like to see
Steve Chamow
host this event.

Past dates

Thu, Apr 16
Thu, Apr 16
6pm PT / 9pm ET
60 min
Tue, May 5
Tue, May 5
5pm PT / 8pm ET
60 min
Tue, May 19
Tue, May 19
5pm PT / 8pm ET
90 min

Description

Dr. Steve Chamow is back by popular demand for an extended conversation on COVID-19 drug development.Event Description: Join Dr. Steve Chamow for a continuation of his first Speakeasy talk: What Does It Take to Develop a New Drug for COVID-19? In this extended conversation, Steve will dive deeper into the availability of technologies for therapeutics and vaccines. He’ll also share opportunities to shorten the timeline of clinical drug development during a public health emergency. Event Location: This event will take place online via Zoom, a free video-conferencing tool. New to Zoom? After you buy your ticket, you'll receive an email with step-by-step instructions on how to use it, and you'll be a pro in no time!Steve’s Bio: Dr. Steven Chamow has over 30 years of experience in biopharmaceutical product development. Since 2008, he has served as president of Chamow & Associates, Inc., a consulting group working with biotechnology companies to design and implement strategies to develop new therapeutic products. In his career, he has contributed to the development of three marketed biologics (Avastin, Natrecor, Vectibix). Prior to his current position, he was Senior Vice President, CMC, at Intradigm Corporation, a private biopharmaceutical company focused on developing RNAi therapeutics (acquired by Silence Therapeutics). Dr. Chamow was Vice President, Process Sciences, at Genitope Corporation and at Abgenix, Inc., (acquired by Amgen) where he built the company’s process sciences department and helped to lead the design and construction of Abgenix’ award-winning production facility in Fremont, CA (sold by Amgen to Boehringer-Ingelheim to become its first North American production facility). Before Abgenix, he served as Director of Biopharmaceutical Development at Scios, Inc. (acquired by J&J), and as a scientist and senior scientist in process development at Genentech, Inc. (acquired by Roche). Dr. Chamow was educated at the University of California (UC Santa Cruz, B.A. in biology; UC Davis, Ph.D. in biochemistry), and completed postdoctoral training at the National Institutes of Health in Bethesda, MD. He is author or co-author of more than 50 scientific publications and patents and co-editor of two books.About Speakeasy: Speakeasy offers intimate events with compelling speakers and performers online via Zoom. Learn more about Speakeasy, and check out a list of all of our events.

flag
Report this event

What to expect